Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 3 Interventional

Long-Term Safety, Efficacy, and Durability of EN3835 in the Treatment and Retreatment of Plantar Fibromatosis

ClinicalTrials.gov ID: NCT05254457

Public ClinicalTrials.gov record NCT05254457. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 29, 2026, 5:27 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Multi-Center, Open-Label, Extension Study to Evaluate the Long-Term Safety, Efficacy, and Durability of EN3835 in the Treatment and Retreatment of Plantar Fibromatosis

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

Assess the long-term safety and efficacy of EN3835 in participants who have participated in a parent placebo-controlled study of EN3835 (EN3835-222, NCT05152173) and assess the efficacy and safety of EN3835 in the treatment and retreatment of plantar fibromatosis.

Study identification

NCT ID
NCT05254457
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Enrollment
145 participants

Conditions and interventions

Interventions

Biological

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Feb 14, 2022 (Actual)
Primary completion
Mar 21, 2024 (Actual)
Completion
Mar 21, 2024 (Actual)
Last update posted
Mar 21, 2025

2022 – 2024

United States locations

U.S. sites
27
U.S. states
11
U.S. cities
25
Facility City State ZIP Site status
Endo Clinical Trial Site #12 Bakersfield California 19331 —
Endo Clinical Trial Site #3 Fresno California 93710 —
Endo Clinical Trial Site #23 La Mesa California 91942 —
Endo Clinical Trial Site #13 Tarzana California 91356 —
Endo Clinical Trial Site #15 Vista California 92083 —
Endo Clinical Trial Site #18 Whittier California 90603 —
Endo Clinical Trial Site #24 Miami Florida 33176 —
Endo Clinical Trial Site #8 Pinellas Park Florida 33782 —
Endo Clinical Trial Site #21 Sweetwater Florida 33172 —
Endo Clinical Trial Site #22 Lawrenceville Georgia 30043 —
Endo Clinical Trial Site #25 Meridian Idaho 83642 —
Endo Clinical Trial Site #19 Decatur Illinois 62521 —
Endo Clinical Trial Site #2 O'Fallon Illinois 62269 —
Endo Clinical Trial Site #14 Springfield Illinois 62704 —
Endo Clinical Trial Site #6 Pasadena Maryland 21122 —
Endo Clinical Trial Site #16 Jefferson City Missouri 65109 —
Endo Clinical Trial Site #9 York Pennsylvania 17402 —
Endo Clinical Trial Site #4 Bedford Texas 76021 —
Endo Clinical Trial Site #17 Dallas Texas 75208 —
Endo Clinical Trial Site #26 Dallas Texas 75251 —
Endo Clinical Trial Site #5 Fort Worth Texas 76104 —
Endo Clinical Trial Site #27 Georgetown Texas 78628 —
Endo Clinical Trial Site #7 Houston Texas 77027 —
Endo Clinical Trial Site #10 Houston Texas 77095 —
Endo Clinical Trial Site #1 McAllen Texas 78501 —
Endo Clinical Trial Site #11 Salt Lake City Utah 84107 —
Endo Clinical Trial Site #20 Suffolk Virginia 23434 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT05254457, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Mar 21, 2025 · Synced Oct 29, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT05254457 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →